Clover Biopharmaceuticals, Ltd. CBPHF
The SEC does not publish structured financial data (XBRL) for Clover Biopharmaceuticals, Ltd., so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Apr 29, 2026 | — |
| D/A | Filing | Apr 28, 2025 | — |
| D | Filing | Apr 12, 2024 | — |
| D/A | Filing | May 9, 2023 | — |
| D/A | Filing | May 24, 2022 | — |
| D | Filing | Apr 28, 2021 | — |
Company profile
- Listed as
- CBPHF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Chengdu, China
- SEC CIK
- 1856491
Source: SEC EDGAR filings. This is company-reported data, not investment advice.